In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test ...
Market OutlookThe global in vitro toxicity testing market is expected to expand at a compound annual growth rate of around 10% during the forecast period, reflecting the increasing need for safer, ...
Association of a Lay Health Worker–Led Intervention on Goals of Care, Quality of Life, and Clinical Trial Participation Among Low-Income and Minority Adults With Cancer We used a simplified version of ...
The FDA cleared its first in vitro test to help determine whether people showing signs of cognitive decline also carry one of the hidden hallmarks of Alzheimer’s disease. The diagnostic detects ...
Common Mistakes to Avoid in Order to Improve Translation of Interaction Data to the Clinic Since 2006, when the U.S. FDA published a draft guidance on drug interaction studies, it has expected new ...
Credit: Getty Images. The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is intended to be used as an aid in adults 55 years of age and older presenting with cognitive impairment who are being evaluated ...
SAN DIEGO--(BUSINESS WIRE)--ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) ...
A new consensus by a team of experts in China has been established to guide researchers in evaluating the percutaneous absorption of cosmetic functional ingredients using in vitro diffusion cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results